Advertisement
Screener

NORTHWEST BIOTHERAPEUTICS INC (NWBO) Contractual Interest Expense on Prepetition Liabilities Not Recognized in Statement of Operations

1.9 / 5 stars · 39/103 Roast Me

NORTHWEST BIOTHERAPEUTICS INC Contractual Interest Expense on Prepetition Liabilities Not Recognized in Statement of Operations

NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Contractual Interest Expense on Prepetition Liabilities Not Recognized in Statement of Operations of $20.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.

Discontinued › Expense Statement › Interest Expense

us-gaap:ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations · last filed 2021-03-31

  • NORTHWEST BIOTHERAPEUTICS INC contractual interest expense on prepetition liabilities not recognized in statement of operations for the quarter ending 2020-12-31 was $1.00K, a 50.00% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC contractual interest expense on prepetition liabilities not recognized in statement of operations for the quarter ending 2020-09-30 was $8.00K, a 77.78% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC contractual interest expense on prepetition liabilities not recognized in statement of operations for the quarter ending 2020-06-30 was $7.00K, a 94.89% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC contractual interest expense on prepetition liabilities not recognized in statement of operations for the quarter ending 2020-03-31 was $4.00K, a 97.91% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC contractual interest expense on prepetition liabilities not recognized in statement of operations for fiscal 2020 was $20.00K, a 94.54% decline from fiscal 2019.
  • NORTHWEST BIOTHERAPEUTICS INC contractual interest expense on prepetition liabilities not recognized in statement of operations for fiscal 2019 was $366.00K.
  • NORTHWEST BIOTHERAPEUTICS INC contractual interest expense on prepetition liabilities not recognized in statement of operations for fiscal 2015 was $640.00K, a 99.38% increase from fiscal 2014.
  • NORTHWEST BIOTHERAPEUTICS INC contractual interest expense on prepetition liabilities not recognized in statement of operations for fiscal 2014 was $321.00K.
Period endContractual Interest Expense on Prepetition Liabilities Not Recognized in Statement of Operations 3 monthContractual Interest Expense on Prepetition Liabilities Not Recognized in Statement of Operations 6 monthContractual Interest Expense on Prepetition Liabilities Not Recognized in Statement of Operations 9 monthContractual Interest Expense on Prepetition Liabilities Not Recognized in Statement of Operations 12 month
2020-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
$9.00K
derived: sum of 2 quarters · filed 2021-03-31
$16.00K
derived: sum of 3 quarters · filed 2021-03-31
$20.00K
10-K · filed 2021-03-31
2020-09-30$8.00K
10-Q · filed 2021-01-15
$15.00K
derived: sum of 2 quarters · filed 2021-01-15
$19.00K
10-Q · filed 2021-01-15
$21.00K
derived: sum of 4 quarters · filed 2021-03-31
2020-06-30$7.00K
10-Q · filed 2020-08-10
$11.00K
10-Q · filed 2020-08-10
$13.00K
derived: sum of 3 quarters · filed 2021-03-31
$49.00K
derived: sum of 4 quarters · filed 2021-03-31
2020-03-31$4.00K
10-Q · filed 2020-06-24
$6.00K
derived: sum of 2 quarters · filed 2021-03-31
$42.00K
derived: sum of 3 quarters · filed 2021-03-31
$179.00K
derived: sum of 4 quarters · filed 2021-03-31
2019-12-31$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
$38.00K
derived: sum of 2 quarters · filed 2021-03-31
$175.00K
derived: sum of 3 quarters · filed 2021-03-31
$366.00K
10-K · filed 2021-03-31
2019-09-30$36.00K
10-Q · filed 2021-01-15
$173.00K
derived: sum of 2 quarters · filed 2021-01-15
$364.00K
10-Q · filed 2021-01-15
2019-06-30$137.00K
10-Q · filed 2020-08-10
$328.00K
10-Q · filed 2020-08-10
2019-03-31$191.00K
10-Q · filed 2020-06-24
2016-03-31$137.00K
10-Q · filed 2016-05-11
$275.00K
derived: sum of 2 quarters · filed 2016-05-11
$426.00K
derived: sum of 3 quarters · filed 2016-05-11
$561.00K
derived: sum of 4 quarters · filed 2016-05-11
2015-12-31$138.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16
$289.00K
derived: sum of 2 quarters · filed 2016-03-16
$424.00K
derived: sum of 3 quarters · filed 2016-03-16
$640.00K
10-K · filed 2016-03-16
2015-09-30$151.00K
10-Q · filed 2015-11-09
$286.00K
derived: sum of 2 quarters · filed 2015-11-09
$502.00K
10-Q · filed 2015-11-09
2015-06-30$135.00K
10-Q · filed 2015-08-10
$351.00K
10-Q · filed 2015-08-10
2015-03-31$216.00K
10-Q · filed 2016-05-11
2014-12-31$321.00K
10-K · filed 2016-03-16